Loading...
Loading...
shares climbed 52.90 percent to $2.11 as the company reported that its Aishuo App has won an exclusive VoIP-supply contract for a Chinese satellite operator KeyIdea Information Technology Co., Ltd.
Eleven Biotherapeutics Inc EBIO shares rose 48.17 percent to $6.06. Eleven Biotherapeutics reported a Q2 loss of $0.36 per share on revenue of $114 thousand.
ImmunoCellular Therapeutics Ltd IMUC gained 29.89 percent to $0.565 as the company announced an agreement with the FDA on a Special Protocol Assessment for ICT-107 Phase 3 registrational trial in glioblastoma.
Planar Systems, Inc.PLNR shares jumped 31.99 percent to $6.14 after the company agreed to be acquired by Leyard for $6.58 per share.
Galectin Therapeutics IncGALT rose 23.55 percent to $2.94 after the company reported that it has received U.S. Patent notice of allowance for use of Pectin compounds to reduce fibrosis in multiple diseases.
CVD Equipment CorporationCVV shares gained 21.64 percent to $12.59. CVD reported quarterly earnings of $0.21 per share on revenue of $10.4 million.
rose 17.18 percent to $1.50 on upbeat Q2 earnings.
Appliance Recycling Centers of AmericaLoading...
Loading...
shares gained 12.20 percent to $1.38 after the company reported Q2 earnings of $0.10 per share on revenue of $30.2 million.
GW Pharmaceuticals PLC- ADR GWPH shares surged 7.21 percent to $110.96. Morgan Stanley initiated coverage on GW Pharmaceuticals with a Overweight rating and a $150.00 price target.
News CorpNWSA rose 6.55 percent to $15.05 after the company reported stronger-than-expected earnings for its fiscal fourth quarter. The company also reported that it is reviewing strategic options for its Amplify education unit.
Inotek Pharmaceuticals CorpITEK shares gained 5.93 percent to $14.30 after the company priced its 5.4 million share offering at $12.75 per share.
Cisco Systems, Inc. CSCO shares gained 3.73 percent to $28.94 after the company reported better-than-expected results for its fiscal fourth quarter on Wednesday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in